Javier Munoz, MD, MS, FACP
Advertisement
Articles by Javier Munoz, MD, MS, FACP
Javier Munoz, MD, MS, FACP, of the Mayo Clinic, considers the appropriateness for CAR T-cell therapy for a 66-year-old woman with relapsed/refractory mantle cell lymphoma.
Advertisement
Latest Updated Articles
Mantle Cell Lymphoma: Overview and Standard of CarePublished: August 28th 2020 | Updated:
R/R MCL: Treating With CAR-TPublished: August 28th 2020 | Updated:
Rationale for CAR-T to Treat R/R MCLPublished: August 28th 2020 | Updated:
Case Overview: 66-Year-Old Woman With MCLPublished: August 28th 2020 | Updated:
Next Steps in Research in R/R MCLPublished: August 28th 2020 | Updated:
R/R MCL: Applying Data Into Clinical PracticePublished: August 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
4
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
5